| abstract |
The present invention relates to a method for identifying a parvovirus mutant structural protein capable of specifically binding to a binding agent for an antigen, a parvovirus mutant structural protein comprising at least one B cell epitope that is heterologous to parvovirus, and a large amount comprising said protein The present invention relates to a body structure, a nucleic acid encoding the protein, a virus or a cell containing the protein, a method for preparing the protein, a drug containing the protein, nucleic acid, or multimeric structure and use thereof. |